Dr. Amezcua Lopez Jesus Alonso | University of Guadalajara | Mexico
Dr. Jesús Alonso Amezcua López is a distinguished Research Professor at the Universidad de Guadalajara, México. His expertise spans biotechnology, neonatal nutrition, and applied food sciences, with a special focus on human milk research. He has pioneered groundbreaking techniques, most notably the patented process for powdered human milk, which has had a transformative impact on neonatal intensive care worldwide. With over three decades of combined academic and applied contributions, he continues to advance innovations that merge scientific excellence with clinical applications. His leadership extends beyond research, influencing policy, medical practice, and education in the fields of biotechnology and public health.
Profile
Education
Dr. Amezcua holds a PhD in Biotechnological Processes, complemented by degrees in Food and Biotechnology Engineering. His academic foundation bridges life sciences with technological innovation, allowing him to integrate engineering principles with biomedical research. Through his doctoral and postdoctoral work, he specialised in neonatal nutrition, microbiota, and bioprocesses, establishing himself as a global authority in applied biotechnology. His educational journey reflects a multidisciplinary approach that empowers him to address challenges in health, food science, and medical biotechnology, preparing him to train future researchers and healthcare professionals while driving high-impact translational research across academia and clinical practice.
Experience
Professor, Dr. Amezcua has cultivated extensive experience in higher education, mentorship, and applied biotechnology projects. He has supervised numerous undergraduate and doctoral theses, shaping the next generation of researchers. His international collaborations extend to hospitals, milk banks, and universities, where he contributes expertise in neonatal health and microbiological safety. He has led consultancy projects in food processing technologies, bridging academia with industry in the United States and Latin America. With patents, books, and indexed publications, his experience demonstrates a career dedicated to scientific innovation, knowledge transfer, and health improvement for vulnerable populations such as preterm infants.
Research Interest
Dr. Amezcua’s primary research interests focus on applied biotechnology, neonatal nutrition, and human milk science. His work investigates the role of probiotics in neonatal health, the nutritional profile of breast milk under various conditions, and innovative processing techniques to preserve bioactive compounds. He integrates microbiological, biochemical, and clinical approaches to design practical solutions for healthcare providers and families. By exploring the relationship between maternal diet, milk microbiota, and infant development, his research directly informs hospital practices and policy. His pioneering studies have expanded global understanding of safe, effective infant feeding practices, particularly in neonatal intensive care environments.
Award
Dr. Amezcua has earned recognition for his outstanding contributions to science and healthcare. His patented method of human milk powder production has redefined neonatal nutrition and influenced global milk bank practices. Through his pioneering innovations, he has safeguarded thousands of preterm infants and critically ill neonates worldwide. His international collaborations, impactful publications, and dedication to translational research demonstrate his capacity to bridge laboratory science with clinical application. Nomination for the Best Researcher Award reflects not only his scientific achievements but also his unwavering commitment to public health, patient safety, and the advancement of biotechnology as a tool for human welfare.
Publication Top Notes
Lactiplantibacillus sp. LH01 as an Adjuvant to Reduce Antibiotic Use in Recurrent Urinary Tract Infections in a Paediatric Patient with Hydronephrosis
Authors: Naomi Aguirre Hernández, Daniel Pérez-Rulfo Ibarra, Blanca Rosa Aguilar Uscanga, Elisa García Morales, Ixtlilxochitl Flores Fong, Jesús Alonso Amezcua López
Journal: Applied Sciences
Presence of Lactic Acid Bacteria and Nutritional Content in Human Milk in Vaccinated and COVID-19 Infected Mothers
Authors: Ixtlilxochitl Flores-Fong, Juan A. Pérez-Montaño, Jesús Alonso Amezcua López, et al.
Journal: Microbiology & Infectious Diseases
Effectiveness of Powdered Human Milk in the Nutrition of a Premature Newborn with Prenatal Exposure to Toxic Substances: A Clinical Case Report
Authors: Jesús Alonso Amezcua López, et al.
Journal: EC Clinical and Medical Case Reports
Effects of Maternal Toxic Substance Consumption During Breastfeeding on Lactic Acid Bacteria Abundance and Nutritional Content
Authors: Jesús Alonso Amezcua López, Elisa García Morales, Daniel Pérez-Rulfo Ibarra, Jorge R. Solís Pacheco, Blanca Rosa Aguilar Uscanga
Journal: International Journal of Medical Sciences
Breastfeeding and Gestational Diabetes: Overview in México
Authors: Blanca Rosa Aguilar Uscanga, Jesús Alonso López, Jorge R. Solís Pacheco, Sara B. Pérez-Elizondo, et al.
Journal: Pregnancy & Women’s Health Care International Journal
Conclusion
Dr. Jesús Alonso Amezcua López exemplifies the fusion of science, innovation, and healthcare application. His visionary leadership has not only advanced neonatal nutrition but also reshaped clinical practices in milk banks and intensive care units. Through patents, publications, and international collaborations, he has built a legacy of applied research that improves health outcomes for the most vulnerable populations. His candidacy for the Best Researcher Award highlights his achievements and future potential, positioning him as a global leader whose work will continue to inspire innovation, safeguard infants, and strengthen the link between biotechnology and human wellbeing.